— Know what they know.
Not Investment Advice

AMRX NASDAQ

Amneal Pharmaceuticals, Inc.
1W: +1.6% 1M: -3.1% 3M: -14.3% YTD: -1.9% 1Y: +67.4% 3Y: +511.8% 5Y: +120.2%
$12.42
+0.00 (+0.00%)
 
Weekly Expected Move ±4.3%
$11 $11 $12 $12 $13
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Sell · Power 45 · $4.0B mcap · 156M float · 1.18% daily turnover · Short 58% of daily vol

📊 Key Metrics

TTM
$3B
Revenue
+7.6% YoY
$122M
Net Income
+1037.8% YoY
$205M
Free Cash Flow
-12.3% YoY
44.3%
Gross Margin
18.5%
Op. Margin
8.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-135.9%
ROA3.4%
ROIC15.2%

Valuation

P/E33.4
P/B-90.0
EV/EBITDA10.4

Leverage

Debt/Equity-38.65
Current Ratio2.17
Interest Cov.1.8x

Quality Scores

Piotroski F8/9
Altman Z2.00
Beneish M-2.75

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms